Eli Lilly (LLY) Interest Expenses (2009 - 2012)

Eli Lilly (LLY) has 4 years of Interest Expenses data on file, last reported at $45.3 million in Q1 2012.

• For the quarter ending Q1 2012, Interest Expenses fell 1.09% year-over-year to $45.3 million; the trailing twelve-month figure through Dec 2012 stood at $45.3 million (down 75.65% YoY), and the FY2011 full-year result was $186.0 million, changed 0.27% from the prior year.
• Interest Expenses for Q1 2012 stood at $45.3 million, down from $50.1 million in the prior quarter.
• Across five years, Interest Expenses topped out at $64.3 million in Q2 2009 and bottomed at $43.2 million in Q4 2010.
• The 4-year median for Interest Expenses is $46.5 million (2010), against an average of $48.1 million.
• The widest annual swing landed in 2010, when Interest Expenses decreased 26.13%; it then rose 15.97% in 2011.
• A 4-year view of Interest Expenses shows it stood at $64.3 million in 2009, then tumbled by 32.81% to $43.2 million in 2010, then advanced by 15.97% to $50.1 million in 2011, then dropped by 9.58% to $45.3 million in 2012.
• The last three Interest Expenses figures came in at $45.3 million (Q1 2012), $50.1 million (Q4 2011), and $45.0 million (Q3 2011), per Business Quant data.

Peer Comparison